|Publication number||US3858583 A|
|Publication date||7 Jan 1975|
|Filing date||28 Jan 1974|
|Priority date||26 Feb 1973|
|Also published as||CA1048884A, CA1048884A1, DE2408791A1, DE2408791C2|
|Publication number||US 3858583 A, US 3858583A, US-A-3858583, US3858583 A, US3858583A|
|Inventors||Hallworth Gerald Wynn, Smith Sidney William|
|Original Assignee||Allen & Hanburys Ltd|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (5), Referenced by (37), Classifications (8)|
|External Links: USPTO, USPTO Assignment, Espacenet|
United States Patent [1 1 Hallworth et al.
-1 11 3,858,583 [4 st Jan.7, 1975 MEDICAMENT INHALATION DEVICE  Assignee: Allen & Hansburys Limited,
London, England 22 Filed: Jan. 28, 1974 21 Appl. No.: 436,993
 Foreign Application Priority Data 1 Feb. 26; 1973 Great Britain 9246/73  U.S. Cl 128/266, 128/206, 12'8/208  Int. Cl. A6lm 13/00, A6lm 15/06  Field ofSearch 128/266, 206, 208
 v References Cited UNITED STATES PATENTS I 2,517,482 8/1950 Hall 128/206 3,507,277 4/1970 Altounyan et al. 128/208 3,635,219 l/l972 Altounyan et al. 128/266 3,669,113 6/1972 Altounyan et al. 128/266 3,807,400 4/1974- Cocozza 128/266 Primary Examiner-Aldrich F. Medbery Attorney, Agent, or Firm-William R. Liberman  ABSTRACT An inhalation device comprises a body with a dispersion chamber. A rotor is arranged in the chamber and is caused to rotate by passage of air through the chamber. One or more air inlet apertures open into the chamber around the rotor. A mouthpiece communicates with the chamber and airfrom the chamber can be inhaled through this mouthpiece. A capsuleretaining pocket is arranged to receive .a pierced capsule and opens into the chamber. Inhalation of air through the mouthpiece will rotate the rotor, vibrate the capsule, draw medicament from the medicament containing capsule through the chamber and out through the mouthpiece.
5 Claims,,5 Drawing Figures MEDICAMENT INHALATION DEVICE BACKGROUND OF THE INVENTION It is well known to administer powdered medicament to the lung bronchioles of a patient by means of inhalation devices having mouthpieces which enable themedicament to be inhaled through the mouth of the patient. The medicament is supplied in capsules which are inserted in the device and pierced prior to use after which inhalation through the mouthpiece will cause the powdered medicament to be released from the capsule and to pass to the patient. An object of the present invention is to provide an improved such inhalation device which has a low resistance to air flow and an ability to discharge the contents of the capsule which makes it particularly suitable for use in the treatment of asthmatic patients.
BRIEF SUMMARY OF THE INVENTION According to the present invention, an inhalation device comprises a body with a dispersion chamber therein, a rotor which is rotatable in the chamber by passage of air therethrough, one or more air inlet apertures in the body, the said apertures opening into the chamber around the rotor, a mouthpiece through which air from the chamber can be inhaled, and a capsule retaining pocket arranged to receive a pierced capsule and opening into the chamber whereby inhalation of air through the mouthpiece will draw medicament from the capsule, through the chamber and out through the mouthpiece and will at the same time rotate the rotor. Preferably, the rotor is arranged to brush the end of a capsule in the capsule-retaining pocket as the rotor rotates. This causes the capsule to vibrate. Such vibration of the capsule makes it possible to empty capsules containing cohesive powders and to dispense them satisfactorily, but is not necessary with capsules charged with easily dispersible powders.
BRIEF DESCRIPTION OF ACCOMPANYING DRAWINGS FIG. 1 is a longitudinal sectional view of an inhalation device according to the invention FIG. 2 is an end elevation,
FIG. 3 is an elevation of the opposite end,
FIG. 4 is a transverse section on line X-X of FIG. 1, and
FIG. 5 is a detail view of a rotor,
DESCRIPTION OF PREFERRED EMBODIMENTS In the illustrated embodiment of the invention, an inhalation device comprises a cylindrical body 1 with a cylindrical dispersion chamber 2 therein. The chamber 2 is closed at one end by an end wall 3 and a mouthpiece 4 is fitted to the body at the other end of the chamber. A rotor 5 is arranged inside the dispersion chamber 2. This rotor 5 is a free-running multi-bladed wheel mounted on a central spindle 6 running axially of the cylindrical chamber. The rotor illustrated has two blades extending radially outwards from the central spindle sleeve 7. Any number of blades can be used, though two to four blades are preferred. The blades can be set at any desired angle and/or can be curved. The rotor must be light in weight and is. for example. of plastics material. The spindle sleeve 7 must he a close fit on the spindle 6 and the rotor is rotatable about the spindle.
One end of the spindle 6 is mounted in a cross-bar 8 extending across the mouthpiece 4. The rotor islocated at the opposite end by means of an end stop plug 9 which is firmly fixed in the spindle sleeve 7. A pointed end of the spindle 6 bears against the internal end of the plug 9. This arrangement prevents axial displacement of the rotor 5. Powder cannot enter the spindle sleeve 7.
One or more air inlet apertures 10 extend through the cylindrical body 1 and open into the dispersion chamber 2. These apertures 10 are in the form of slots which run lengthwise of the body' and are disposed at an angle which is conveniently tangential to the rotor.
The body is also provided with a capsule-retaining pocket 11..This pocket 11 is arranged at or near the closed end 3 of the dispersion chamber and has an opening leading into a recess 12 in the end wall 3 of the dispersion chamber. The pocket is arranged to receive a hard gelatine capsule 13 containing a powdered medicament.
The rotor 5 is so positioned with respect to its spindle 6 and the end wall 3 that it brushes lightly against the end of the capsule l3 protruding from the recess 12. The rotation of the rotor therefore causes the capsule 13 to vibrate and this assists in the emptying of cohesive powders from the capsule and the dispersion of such powders. If the device is intended for use with only capsules containing easily dispensible powders it is not necessary to arrange for the rotor to brush the capsules.
The body is provided at one end with a piercing needle 14 for piercing the ends of the capsule 13. This needle 14 is located in a capsule piercing pocket 15 in the end wall 3 of'the body. The capsule 15 can then be inserted into the pocket 15 and pressed against the pointed end of the needle 14, to pierce the capsule and can then be placed in the capsule-retaining pocket 11. A stirrup securing means is hingedly mounted on the body 1 and can, as shown in FIG. 1 be swung to and from a position in which it extends across the open end of the capsule and retaining pocket 11 to secure and prevent egress of the capsule.
It has been found that powder dispersion is improved by providing one of the blades of the rotor with a cut away 17 to provide unbalance and vibration to the rotor. The end of the rotor which brushes against the capsule is preferably provided with a bevel 18.
The device is, except for the spindle 6 and needle 14 made of plastics material, preferably one which has a high resistance to the build up of static electricity.
In use, a capsule 13 is pierced at both ends by means of needle 14 and is then fitted in the pocket 11. The patient then applies the mouthpiece 4 to the mouth and draws in air through the mouthpiece. The greater part of the inhaled air will enter the chamber through the tangential slots 10 and this will cause the rotor 5 to rotate rapidly. However, a portion of the inhaled air is drawn into the chamber 2 through the capsule 13 and this causes the rapid emptying of the powdered medicament into the dispersion chamber 2. The rotation of the rotor S and the turbulent air flow within the dispersion chamber 2 will cause the efficient dispersion of the powdered medicament into the air being inhaled by the patient.
With this device there is provided an excellent deep lung and upper lung penetration of the drug. The resistance to air flow can be low, for example at 2.5 cm.
water gauge at 60l/min air flow. The vibration set up by the brushing of the rotor bevel against the capsule assists in the dispersion of the powder prior to the emptying of the capsule. If a freerer flowing powder is used the brushing arrangement may be dispensed with and the unbalanced rotor would then assist in the emptying of the capsule.
What is claimed is:
1. A medicament inhalation device comprising a body with a dispersion chamber therein, a rotor mounted in one end of said chamber and which is rotatable in the chamber by passage of air there through, at least one air inlet aperture in the body, the said apertures opening into the chamber around the rotor, a mouthpiece on one end of the body through which air from the chamber can be inhaled, and a capsuleretaining pocket in and adjacent the other end of said body and in proximinity to said rotors other end to receive a pierced medicament containing capsule and opening into the chamber, a means for providing vibration and passage of medicament from said capsule comprising a capsule contacting means on the other end of said rotor whereby inhalation of air through the mouthpiece will turn said rotor to vibrate and draw medicament from the capsule through the chamber and out through the mouthpiece into the patient.
2. A device as claimed in claim 1, wherein the body has a capsule-piercing pocket in which a capsule can be removably inserted and pressed against a point in the pocket thereby to pierce the capsule.
3. A device as claimed in claim 2, wherein the rotor is mounted on a spindle carried by a cross-bar extending across the mouthpiece and said capsule contacting means is a bevel on one and of said rotor.
4. A device as claimed in claim 3, wherein the capsule retaining pocket is arranged so that one end of a capsule located therein extends into the dispersion chamber and the rotor is so positioned as to brush against the protruding end of the capsule as it rotates.
5. A device as claimed in claim 1, wherein the rotor includes two blades extending radially and oppositely outwards from a spindle sleeve, one of the said blades having a cut-away portion to provide an unbalance condition for vibration.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2517482 *||9 Apr 1949||1 Aug 1950||Sharp & Dohme Inc||Inhaler|
|US3507277 *||15 Sep 1967||21 Apr 1970||Fisons Pharmaceuticals Ltd||Inhalation device|
|US3635219 *||4 Jun 1969||18 Jan 1972||Fisons Pharmaceuticals Ltd||Inhalation device|
|US3669113 *||18 Jun 1969||13 Jun 1972||England Eunice Cockburn Howell||Inhalation device|
|US3807400 *||26 Jun 1972||30 Apr 1974||Isf Spa||Inhaling device for medicinal powder compositions|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3938516 *||13 Jan 1975||17 Feb 1976||Syntex Puerto Rico, Inc.||Inhalation device|
|US3964483 *||13 Jan 1975||22 Jun 1976||Syntex Puerto Rico, Inc.||Inhalation device|
|US3973566 *||13 Jan 1975||10 Aug 1976||Syntex Puerto Rico Inc.||Inhalation device|
|US4005711 *||13 Jan 1975||1 Feb 1977||Syntex Puerto Rico, Inc.||Inhalation device|
|US4014336 *||20 Nov 1975||29 Mar 1977||Syntex Puerto Rico, Inc.||Inhalation device|
|US4192309 *||5 Sep 1978||11 Mar 1980||Syntex Puerto Rico, Inc.||Inhalation device with capsule opener|
|US4620847 *||6 May 1984||4 Nov 1986||Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov||Device for administering powdered substances|
|US4645487 *||5 Jun 1984||24 Feb 1987||Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov||Device for administering powdered substances|
|US4860740 *||10 Feb 1987||29 Aug 1989||Riker Laboratories, Inc.||Powder inhalation device|
|US5161524 *||2 Aug 1991||10 Nov 1992||Glaxo Inc.||Dosage inhalator with air flow velocity regulating means|
|US5372128 *||14 Apr 1993||13 Dec 1994||Habley Medical Technology Corporation||Fluidizing powder inhaler|
|US5388572 *||26 Oct 1993||14 Feb 1995||Tenax Corporation (A Connecticut Corp.)||Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same|
|US5388573 *||2 Dec 1993||14 Feb 1995||Tenax Corporation||Dry powder inhalator medicament carrier|
|US5460173 *||25 Mar 1994||24 Oct 1995||Tenax Corporation||Dry powder inhaler medicament carrier|
|US6098618 *||13 Mar 1998||8 Aug 2000||Astra Aktiebolag||Inhalation device|
|US6257232||13 Mar 1998||10 Jul 2001||Astra Akteibolag||Inhalation device|
|US6655380||13 Mar 1998||2 Dec 2003||Astrazeneca Ab||Inhalation device|
|US7228860 *||9 May 2005||12 Jun 2007||Astrazeneca Ab||Inhaler with vibrational powder dislodgement|
|US7779836||15 Nov 2007||24 Aug 2010||Astrazeneca Ab||Inhalation device|
|US7841340 *||29 Sep 2003||30 Nov 2010||Astrazeneca Ab||Inhaler with powder dislodging member|
|US8127763||6 Oct 2008||6 Mar 2012||Stc.Unm||Dry powder inhaler with aeroelastic dispersion mechanism|
|US8561609||7 Dec 2011||22 Oct 2013||Respira Therapeutics, Inc.||Dry powder inhaler|
|US8651104||11 May 2012||18 Feb 2014||Respira Therapeutics, Inc.||Bead-containing dry powder inhaler|
|US9492625||12 Nov 2010||15 Nov 2016||Stc.Unm||Dry powder inhaler with flutter dispersion member|
|US20040065325 *||29 Sep 2003||8 Apr 2004||Astrazeneca Ab, A Swedish Corporaion||Inhalation device|
|US20050194008 *||9 May 2005||8 Sep 2005||Astrazeneca Ab, A Swedish Corporation||Inhalation device|
|US20070151560 *||14 Jun 2004||5 Jul 2007||Robert Price||Delivery device for a powder aerosol|
|US20070209661 *||2 Mar 2007||13 Sep 2007||Hugh Smyth||Dry powder inhaler with aeroelastic dispersion mechanism|
|US20080092886 *||15 Nov 2007||24 Apr 2008||Astrazeneca Ab, A Sodertalje Sweden Corporation||Inhalation device|
|US20080196717 *||8 Sep 2005||21 Aug 2008||Glaxosmithkline Pharmaceuticals S.A.||Powder Inhaler|
|US20090095294 *||6 Oct 2008||16 Apr 2009||Smyth Hugh C||Dry powder inhaler with aeroelastic dispersion mechanism|
|EP1293225A2 *||13 Sep 2002||19 Mar 2003||Omron Corporation||Dry powder inhaler|
|EP1293225A3 *||13 Sep 2002||20 Aug 2003||Omron Corporation||Dry powder inhaler|
|EP3138600A1 *||4 Sep 2015||8 Mar 2017||Victor Esteve||Dry powder inhaler|
|WO1998041264A1 *||13 Mar 1998||24 Sep 1998||Astra Aktiebolag (Publ)||Inhalation device|
|WO2006033584A1 *||8 Sep 2005||30 Mar 2006||Glaxosmithkline Pharmaceuticals S.A.||Powder inhaler|
|WO2006075184A1 *||16 Jan 2006||20 Jul 2006||Britannia Pharmaceuticals Limited||Apparatus and methods for providing dry powder medicament for inhalation|
|International Classification||A61M15/00, A61M13/00|
|Cooperative Classification||A61M2015/0033, A61M15/0028, A61M2202/064, A61M2015/0008|